Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Heinz-Gerd Weijers.
Neuropsychobiology | 2008
Sandra E. Müller; Heinz-Gerd Weijers; Jobst Böning; Gerhard A. Wiesbeck
Personality traits are important individual characteristics modifying responses to therapy in various diseases. The aim of this study was to identify personality traits that may predict treatment outcome in alcohol-dependent patients. The present analysis was based on a total of 146 alcohol-dependent patients (109 male, 37 female) after detoxification. The variable of interest was treatment outcome (abstinence/relapse) after a 1-year follow-up. To identify personality traits as predictors of treatment outcome, 5 personality questionnaires (NEO 5-Factor Inventory, Temperament and Character Inventory, Eysenck Personality Questionnaire, Eysenck Impulsiveness-Venturesomeness-Empathy Scale and Sensation-Seeking Scale) were applied. Data analysis was performed by using a classification and regression tree analysis (CART; a nonparametric technique for data with a complex structure) in order to find a decision rule to predict treatment outcome from personality traits. The CART model identified psychoticism and persistence as the 2 most relevant discriminatory parameters, of which psychoticism was used as the first node in the model, classifying 64% of the patients correctly as relapsed and 12% correctly as abstinent. In addition, the risk of relapse was even higher in patients with a substantial score in psychoticism and a low score in persistence. When comparing relapsed and abstinent patients, further variables, such as scores for novelty seeking (20.9 ± 5.5 vs. 18.5 ± 5.9) and impulsiveness (8.4 ± 3 vs. 7.2 ± 3.5), showed significance. In addition, relapsed patients lived alone more often than abstinent patients (52 vs. 25%, p = 0.004). In conclusion, this analysis demonstrated that specific personality characteristics, namely psychoticism and persistence, are usable predictors for the risk of relapse in alcohol-dependent patients.
Addiction Biology | 2006
Marc Walter; Urs Gerhard; Manfred Gerlach; Heinz-Gerd Weijers; Jobst Boening; Gerhard A. Wiesbeck
Alcohol‐dependent patients face a substantial risk of relapse after detoxification. A major risk factor for relapse is stress which is reflected biologically by various physiological changes that include an activation of the hypothalamic‐pituitary‐adrenal (HPA) axis and release of glucocorticoids. The prospective study examined cortisol concentrations and stress‐coping styles in relation to abstinence 1 year following discharge from treatment. Cortisol concentrations were measured in the plasma of 46 alcohol‐dependent patients (12 women) on initial presentation for treatment (day 1), and again in plasma and in cerebrospinal fluid (CSF) after 6 weeks of abstinence (day 40). These results were compared with those of 26 age‐ and sex‐matched, healthy control subjects. After withdrawal, the patients completed a comprehensive baseline assessment including a stress‐coping questionnaire (Stressverarbeitungsfragebogen SVF120) and were monitored for 1 year after discharge. Negative stress‐coping styles (e.g. flight, resignation) positively correlated with higher cortisol concentration in plasma and in CSF after withdrawal (day 40). Compared with relapsers after 1 year, abstainers had significantly lower levels for cortisol in CSF, whereas the stress‐coping styles did not differ between abstainers and relapsers in this sample. These findings suggest that relatively stable personality traits like stress‐coping styles have no measurable influence on abstinence. The lower cortisol concentration in CSF as an indicator for HPA axis functioning is associated with long‐term abstinence in detoxified alcoholics.
Neuropsychobiology | 2006
Marc Walter; Urs Gerhard; Kenneth M. Duersteler-MacFarland; Heinz-Gerd Weijers; Jobst Boening; Gerhard A. Wiesbeck
Alcohol-dependent patients face a substantial risk of relapse after detoxification. Though psychosocial stress and coping strategies are regarded as major contributing factors in returning to drinking, the direct effects of coping styles on relapse are not clear. In this treatment outcome study, a mixed gender sample of 130 detoxified and well-characterized alcohol-dependent patients (37 women) was followed up over a period of 12 months after 6 weeks of inpatient treatment. Patients had completed a comprehensive baseline assessment, including a stress coping questionnaire (SVF120). We hypothesized that these individual stress coping styles would contribute to treatment outcome. A logistic regression analysis was used to evaluate the impact of stress coping styles, as well as the effect of pretreatment drinking and social characteristics on relapse. Approximately half the patients (49%) relapsed within 1 year after treatment. In contrast to our hypothesis, stress coping styles did not predict relapse. However, significant predictors of relapse were social factors related to living situation (living alone), marital status (being separated from the spouse) and pretreatment frequency of alcohol intake. These findings suggest that a partnership is more relevant for the risk of relapse than stress coping styles.
World Journal of Biological Psychiatry | 2004
Gerhard A. Wiesbeck; Heinz-Gerd Weijers; Norbert Wodarz; Heike K Keller; Tanja Maria Michel; Martin J. Herrmann; Jobst Boening
Summary We tested the hypothesis of an association between the serotonin transporter (5-HTT) gene regulatory region polymorphism and the Temperament and Character Inventory (TCI) personality dimension of Harm Avoidance. For the study, 124 subjects seeking inpatient treatment for primary alcohol dependence were grouped by their 5-HTT genotype and assessed with the TCI. Genotypes differed statistically significantly in Harm Avoidance but not in any other personality trait. This gives support to the hypothesis that the TCI temperament Harm Avoidance is associated with serotonergic neurotransmission in primary alcohol dependence.
Neuropsychobiology | 2006
Gerhard A. Wiesbeck; Norbert Wodarz; Heinz-Gerd Weijers; Kenneth M. Dürsteler-MacFarland; Friedrich-M. Wurst; Marc Walter; Jobst Boening
Tobacco smoking represents a leading cause of morbidity and mortality with a strong dose-response relation between the amount of smoking and the risks of tobacco-related diseases and death. The quantity that is smoked is determined predominantly by genetic factors. The present study examined whether there is an association between the quantity of cigarettes smoked and length variation of a functional 30-bp repeat polymorphism in the promoter region of the monoamine oxidase A (MAO-A) gene. The number of 30-bp repeats, which is associated with enzyme activity was assessed in 121 Caucasian men suffering from both alcohol and tobacco dependence. Analysis revealed that the highly active long allele (4 repeat) is associated with a significantly greater amount of cigarette smoking in comparison with the less active short allele (3 repeat). In a logistic regression model (dichotomized), smoking quantity was significantly predicted by MAO-A genotype while no other variable (age, height, body weight, frequency of smoking, quantity and frequency of alcohol consumption) met the significance level. Since tobacco smoke is a potent inhibitor of MAO-A, this result could be regarded as a genotype-related dosage effect. Taken together, in alcohol-dependent heavily smoking men there is evidence for a MAO-A gene-associated effect on the quantity that is smoked as reflected by the daily number of cigarettes consumed.
Neuroreport | 1996
Johannes Thome; Nuria Durany; Harsányi A; Paul Foley; Antonio Palomo; Johannes Kornhuber; Heinz-Gerd Weijers; Alessandra Baumer; Michael Rösler; Felix Cruz-Sanchez; Helmut Beckmann; Peter Riederer
The maldevelopmental theory postulates disturbances in neural development as crucial factors in the aetiopathogenesis of schizophrenia. Neurotrophic factors, including ciliary neurotrophic factor (CNTF), play a central role in the regulation of such development. A mutation has been described for the CNTF gene, whereby subjects homozygous for the mutation lack CNTF. The polymerase chain reaction was used to amplify the CNTF gene region containing this mutation in whole blood genomic DNA. The mutation was detected by analysis of restriction fragment length polymorphisms. Patients suffering from schizophrenic psychosis (ICD-10 criteria) (51 from Würzburg, 83 from Barcelona), and healthy controls (62 from Würzburg, 50 from Barcelona) were investigated. In the Würzburg group, the frequency of subjects homozygous or heterozygous for the mutation was significantly higher among schizophrenic patients than in controls. However, no difference could be detected in the Spanish sample; the possible reasons for the different allele distribution in the two patient groups is discussed. It is concluded that the CNTF null mutation may be relevant to the aetiopathogenesis of schizophrenia in some patients, but further work is required to identify specifically the patient group for which it is important.
Psychopathology | 2005
Gerhard A. Wiesbeck; Kenneth M. Dürsteler-MacFarland; Marc Walter; Heinz-Gerd Weijers; Jobst Boening
Subtyping of alcoholics according to specific characteristics has a long tradition in alcoholism research with a number of different typologies that emerged in the literature. The goal of the present study was to test a multidimensional approach of subtyping with characteristics from different axes. Therefore, male inpatients meeting ICD-10 criteria for alcohol dependence were rated on three axes by assessing their degree of sensation seeking (personality axis), age of alcoholism onset (clinical axis) and level of dopamine activity (neurobiological axis). By using a configuration frequency analysis, we identified a subtype that was characterized by high sensation seeking early age of alcoholism onset and high dopamine activity. This subtype, which is in accordance with clinical experience and cannot be explained by antisocial personality disorder, embodied a significantly greater proportion of alcoholics than expected. The result emphasizes the usefulness of multidimensional approaches integrating personality, clinical and neurobiological characteristics.
Alcoholism: Clinical and Experimental Research | 2005
L G. Schmidt; Stefan Bleich; J Boening; G Buehringer; Johannes Kornhuber; Heinz-Gerd Weijers; Gerhard A. Wiesbeck; J Wolfgramm; U. Havemann-Reinecke
This article presents the proceedings of a symposium at the 2004 International Society for Biomedical Research on Alcoholism meeting in Heidelberg/Mannheim, Germany, put together by the German Society of Addiction Therapy and Research (DG-Sucht e.V.). The aim was to give an overview on recent findings from animal to human studies that were conducted by several research groups engaged in the alcoholism field in Germany for longer periods. Results of his animal studies were presented by J. Wolfgramm; G. Buchringer reported on epidemiologic and psychotherapeutic research advances on alcohol-related disorders in Germany. L. G. Schmidt summarized results of novel diagnostic and therapeutic approaches in alcohol dependence, and J. Boening focused on biopsychological personality traits as predictors for relapse in alcoholism. Data relating hyperhomocysteinemia and brain shrinkage in patients with alcoholism were presented by J. Kornhuber. Four addiction research networks federally funded represented their results in separate symposia and were therefore deliberately excluded from this symposium.
Neuropsychobiology | 2008
Sandra E. Müller; Heinz-Gerd Weijers; Jobst Böning; Gerhard A. Wiesbeck; Yong-Ku Kim; Ying-Chieh Wang; Cheryl C.H. Yang; Terry B.J. Kuo; Chul Lee; Chang-Uk Lee; Theresa Schreppel; Johanna Egetemeir; Martin Schecklmann; Michael M. Plichta; Paul Pauli; Heiner Ellgring; Andreas J. Fallgatter; Martin J. Herrmann; Hwa-Young Lee; Ya-Mei Bai; Kyeong-Rin Kwak; Takayuki Nakahachi; Ryouhei Ishii; Masao Iwase; Leonides Canuet; Hidetoshi Takahashi; Ryu Kurimoto; Kouji Ikezawa; Michiyo Azechi; Ryuji Sekiyama
N. Brunello, Milan G. Erdmann, Berlin S. Galderisi, Naples U. Hegerl, Leipzig K. Hirata, Tochigi Y. Koga, Tokyo J. Kornhuber, Erlangen P.T. Loosen, Nashville, Tenn. D. Lehmann, Zürich K.P. Lesch, Würzburg G.N. Papadimitriou, Athens M. Reuter, Bonn F. Rösler, Marburg G. Ruigt, Oss J.K. Rybakowski, Poznan F. Schneider, Aachen D. Souery, Brussels P. Willner, Swansea H. Yoneda, Osaka Associate Editors
American Journal of Neuroradiology | 2001
Martin Bendszus; Heinz-Gerd Weijers; Gerd Wiesbeck; Monika Warmuth-Metz; Andreas J. Bartsch; Stephan Engels; Jobst Böning; Laszlo Solymosi